1. Christiansen C. X-ray contrast media-an overview. Toxicology. 2005; 209:185–187.
Article
2. Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol. 2007; 188:1643–1647.
Article
3. Lee SY, Lim KW, Chang YS. Radiocontrast media hypersensitivity in the Asia Pacific region. Asia Pac Allergy. 2014; 4:119–125.
Article
4. Beckett KR, Moriarity AK, Langer JM. Safe use of contrast media: what the radiologist needs to know. Radiographics. 2015; 35:1738–1750.
Article
5. Bae K, Lee SM, Ha JY, Jeon KN, Moon JI, Choi BH, et al. Adverse drug reactions to CT contrast media in South Korea: incidence and risk factors. J Korean Soc Radiol. 2016; 75:41–48.
Article
6. Kyung EJ, Ryu JH, Kim EY. Evaluation of adverse reactions to contrast media in the hospital. Br J Radiol. 2013; 86:20130418.
Article
7. Napoleone E. Children and ADRs (Adverse Drug Reactions). Ital J Pediatr. 2010; 36:4.
Article
8. Brockow K. Immediate and delayed cutaneous reactions to radiocontrast media. Chem Immunol Allergy. 2012; 97:180–190.
Article
9. Brockow K. Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism? Immunol Allergy Clin North Am. 2009; 29:453–468.
Article
11. Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA. Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital-retrospective analysis of data in 12,494 patients. Radiology. 2009; 250:674–681.
Article
12. Park BB, Park CH, Nho IY, Kim HS, Kang NK, Chang SI, et al. Prevalence and clinical features of hypersensitivity reaction to contrast media after prescreening skin test. Allergy Asthma Respir Dis. 2016; 4:442–448.
Article
13. Kim SS, Park CH, Park MJ, Choi SH, Kim YS, Park HW, et al. Adverse reactions to radio-contrast media in computed tomography (CT) in general population: incidence and clinical features. Korean J Asthma Allergy Clin Immunol. 2007; 27:157–161.
14. Bae YJ, Hwang YW, Yoon SY, Kim S, Lee T, Lee YS, et al. The effectiveness of automatic recommending system for premedication in reducing recurrent radiocontrast media hypersensitivity reactions. PLoS One. 2013; 8:e66014.
Article
15. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990; 175:621–628.
Article
16. Ho J, Kingston RJ, Young N, Katelaris CH, Sindhusake D. Immediate hypersensitivity reactions to IV non-ionic iodinated contrast in computed tomography. Asia Pac Allergy. 2012; 2:242–247.
Article
17. Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008; 191:409–415.
Article
18. Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol. 2009; 193:1124–1127.
Article
19. Mortelé KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol. 2005; 184:31–34.
Article
20. Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, Bircher A, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005; 60:150–158.
Article
21. Ha SO, Kim DY, Sohn YD. Clinical characteristics of adverse reactions to nonionic low osmolality contrast media in patients transferred from the CT room to the emergency room. Springerplus. 2016; 5:929.
Article
22. Goksel O, Aydın O, Atasoy C, Akyar S, Demirel YS, Misirligil Z, et al. Hypersensitivity reactions to contrast media: prevalence, risk factors and the role of skin tests in diagnosis-a cross-sectional survey. Int Arch Allergy Immunol. 2011; 155:297–305.
Article
23. Idée JM, Pinès E, Prigent P, Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol. 2005; 19:263–281.
Article
24. McCormack PL. Iobitridol: a review of its use as a contrast medium in diagnostic imaging. Clin Drug Investig. 2013; 33:155–166.
25. Gomi T, Nagamoto M, Hasegawa M, Katoh A, Sugiyama M, Murata N, et al. Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media? Eur Radiol. 2010; 20:1631–1635.
Article
26. Petersein J, Peters CR, Wolf M, Hamm B. Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol. 2003; 13:2006–2011.
Article
27. Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol. 2007; 189:1533–1538.
Article
28. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media-gadolinium chelates. Br J Radiol. 2006; 79:368–371.
Article